No Data
No Data
Expansion of nano mRNA---mRNA pharmaceutical pipelines and progress in research and development of existing pipelines
NANO MRNA <4571> announced consolidated financial results for the fiscal year ending 2024/3 on the 14th, and held a financial results briefing on the 16th. Net sales decreased 32.9% from the previous fiscal year to 135 million yen, operating loss was 864 million yen (loss of 1,246 billion yen in the previous fiscal year), ordinary loss was 749 million yen (loss of 1,104 billion yen), and net loss attributable to parent company shareholders was 780 million yen (loss of 1,310 million yen). A is the foundation for business promotion in the current fiscal year when the transition to a new business model is
Nano Mrna: Financial results briefing materials for the fiscal year ending 2024/3
Nano Mrna: Summary of Financial Results for the Fiscal Year Ending March 31, 2024 [Japanese GAAP] (Consolidated)
Front market [stocks that have moved, stocks that have been created]
*Socionext <6526> 4670 +681 Morgan Stanley MUFG Securities upgraded investment decisions. *MARUWA <5344> 37100 +4750 Goldman Sachs Securities recommends buying a new one. *Unitika <3103> announced that it has successfully developed a 189 +21 high entropy alloy. *DeNA <2432> 1641 +151 upgraded to buy recommendation at JP Morgan Securities. *TEPCO HD <9501> 100
Is push buying dominant due to steady growth and expectations of a drop in US interest rates
[Emerging Markets Individual Stock Strategy] Today's emerging markets are expected to develop steadily. In the US stock market yesterday 3rd, the Dow Average continued to fall slightly for 3 days to 39127.14 dollars, which depreciated by 43.10 dollars (-0.11%). ADP employment statistics exceeded expectations, and the view that interest rate cuts were even farther away weighed on stock prices. Meanwhile, in addition to the unexpected decline in the March ISM non-manufacturing business climate index, Chairman Powell of the Federal Reserve (Fed) continues to suggest the possibility of interest rate cuts by the end of the year
Front market for high stop and low stop stocks
■Stop High<3137>Fundley <4571>NANO MRNA<7585>Kannan Maru ■Low Stop <4761>Sakura KCS ※Includes temporary stop high/low (indicative value)
No Data